Kit Simpson to Mass Screening
This is a "connection" page, showing publications Kit Simpson has written about Mass Screening.
Connection Strength
0.740
-
Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014 Jun; 41(6):353-8.
Score: 0.304
-
A cost-effectiveness analysis of anal cancer screening in HIV-positive women. J Low Genit Tract Dis. 2012 Jul; 16(3):275-80.
Score: 0.266
-
Economic modeling of HIV treatments. Curr Opin HIV AIDS. 2010 May; 5(3):242-8.
Score: 0.057
-
Economic decision analysis model of screening for lung cancer. Eur J Cancer. 2001 Sep; 37(14):1759-67.
Score: 0.031
-
Leveraging health system telehealth and informatics infrastructure to create a continuum of services for COVID-19 screening, testing, and treatment. J Am Med Inform Assoc. 2020 12 09; 27(12):1871-1877.
Score: 0.030
-
Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gastroenterol. 2000 Nov; 95(11):3250-8.
Score: 0.030
-
Health-care expenditures for tuberculosis in the United States. Arch Intern Med. 1995 Aug 7-21; 155(15):1595-600.
Score: 0.021